메뉴 건너뛰기




Volumn 8, Issue 1, 2013, Pages 277-281

Effect of bortezomib in combination with cisplatin and 5-fluorouracil on 4T1 breast cancer cells

Author keywords

5 Fluorouracil; Bortezomib; Cancer; Cisplatin

Indexed keywords

BORTEZOMIB; CISPLATIN; FLUOROURACIL; PROTEIN P53;

EID: 84878927054     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1466     Document Type: Article
Times cited : (20)

References (17)
  • 1
    • 5344234076 scopus 로고    scopus 로고
    • The ubiquitin-mediated protein degradation pathway in cancer: Therapeutic implications
    • DOI 10.1016/j.ejca.2004.07.006, PII S0959804904005660
    • Burger AM and Seth AK: The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer 40: 2217-2229, 2004. (Pubitemid 39348871)
    • (2004) European Journal of Cancer , vol.40 , Issue.15 , pp. 2217-2229
    • Burger, A.M.1    Seth, A.K.2
  • 2
    • 2342613652 scopus 로고    scopus 로고
    • The proteasome: A suitable antineoplastic target
    • Adams J: The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4: 349-360, 2004.
    • (2004) Nat Rev Cancer , vol.4 , pp. 349-360
    • Adams, J.1
  • 3
    • 47349102144 scopus 로고    scopus 로고
    • Effect of bortezomib on human neuroblastoma: Analysis of molecular mechanisms involved in cytotoxicity
    • Combaret V, Boyault S, Iacono I, Brejon S, Rousseau R and Puisieux A: Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity. Mol Cancer 7: 50, 2008.
    • (2008) Mol Cancer , vol.7 , pp. 50
    • Combaret, V.1    Boyault, S.2    Iacono, I.3    Brejon, S.4    Rousseau, R.5    Puisieux, A.6
  • 4
    • 0142244338 scopus 로고    scopus 로고
    • The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells
    • DOI 10.1038/sj.leu.2403109
    • Pei XY, Dai Y and Grant S: The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells. Leukemia 17: 2036-2045, 2003. (Pubitemid 37322135)
    • (2003) Leukemia , vol.17 , Issue.10 , pp. 2036-2045
    • Pei, X.-Y.1    Dai, Y.2    Grant, S.3
  • 5
    • 65449166841 scopus 로고    scopus 로고
    • Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade
    • Yerlikaya A and Erin N: Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade. Int J Mol Med 22: 817-823, 2008.
    • (2008) Int J Mol Med , vol.22 , pp. 817-823
    • Yerlikaya, A.1    Erin, N.2
  • 6
    • 26844452967 scopus 로고    scopus 로고
    • Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
    • Boccadoro M, Morgan G and Cavenagh J: Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int 5: 18, 2005.
    • (2005) Cancer Cell Int , vol.5 , pp. 18
    • Boccadoro, M.1    Morgan, G.2    Cavenagh, J.3
  • 7
    • 0034902354 scopus 로고    scopus 로고
    • Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappaB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma
    • Sunwoo JB, Chen Z, Dong G, Yeh N, Crowl Bancroft C, Sausville E, Adams J, Elliott P and Van Waes C: Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res 7: 1419-1428, 2001. (Pubitemid 32708698)
    • (2001) Clinical Cancer Research , vol.7 , Issue.5 , pp. 1419-1428
    • Sunwoo, J.B.1    Chen, Z.2    Dong, G.3    Yeh, N.4    Bancroft, C.C.5    Sausville, E.6    Adams, J.7    Elliott, P.8    Van Waes, C.9
  • 9
    • 6344229760 scopus 로고    scopus 로고
    • Proteasome inhibition sensitizes nonsmall cell lung cancer to histone deacetylase inhibitorinduced apoptosis through the generation of reactive oxygen species
    • DOI 10.1016/j.jtcvs.2004.07.010, PII S0022522304009857
    • Denlinger CE, Rundall BK and Jones DR: Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species. J Thorac Cardiovasc Surg 128: 740-748, 2004. (Pubitemid 39388930)
    • (2004) Journal of Thoracic and Cardiovascular Surgery , vol.128 , Issue.5 , pp. 740-748
    • Denlinger, C.E.1    Rundall, B.K.2    Jones, D.R.3
  • 12
    • 77955275936 scopus 로고    scopus 로고
    • Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells
    • Chua BT, Lim SJ, Tham SC, Poh WJ and Ullrich A: Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. Mol Oncol 4: 323-334, 2010.
    • (2010) Mol Oncol , vol.4 , pp. 323-334
    • Chua, B.T.1    Lim, S.J.2    Tham, S.C.3    Poh, W.J.4    Ullrich, A.5
  • 13
    • 84868091512 scopus 로고    scopus 로고
    • The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
    • Yerlikaya A, Okur E and Ulukaya E: The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib. Tumour Biol 33: 1385-1392, 2012.
    • (2012) Tumour Biol , vol.33 , pp. 1385-1392
    • Yerlikaya, A.1    Okur, E.2    Ulukaya, E.3
  • 14
    • 30544432958 scopus 로고    scopus 로고
    • BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53
    • DOI 10.1007/s11373-005-9025-y
    • Basma H, El-Refaey H, Sgagias MK, Cowan KH, Luo X and Cheng PW: BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53. J Biomed Sci 12: 999-1011, 2005. (Pubitemid 43081679)
    • (2005) Journal of Biomedical Science , vol.12 , Issue.6 , pp. 999-1011
    • Basma, H.1    El-Refaey, H.2    Sgagias, M.K.3    Cowan, K.H.4    Luo, X.5    Cheng, P.-W.6
  • 15
    • 33746437215 scopus 로고    scopus 로고
    • Transcriptional profiling of MCF7 breast cancer cells in response to 5-flouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53
    • DOI 10.1002/ijc.21938
    • Hernandez-Vargas H, Ballestar E, Carmona-Saez P, von Kobbe C, Banon-Rodriguez I, Esteller M, Moreno-Bueno G and Palacios J: Transcriptional profiling of MCF7 breast cancer cells in response to 5-fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer 119: 1164-1175, 2006. (Pubitemid 44121416)
    • (2006) International Journal of Cancer , vol.119 , Issue.5 , pp. 1164-1175
    • Hernandez-Vargas, H.1    Ballestar, E.2    Carmona-Saez, P.3    Von Kobbe, C.4    Banon-Rodriguez, I.5    Esteller, M.6    Moreno-Bueno, G.7    Palacios, J.8
  • 17
    • 4444311881 scopus 로고    scopus 로고
    • Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity
    • Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D and Neckers L: Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther 3: 551-566, 2004. (Pubitemid 39193734)
    • (2004) Molecular Cancer Therapeutics , vol.3 , Issue.5 , pp. 551-566
    • Mimnaugh, E.G.1    Xu, W.2    Vos, M.3    Yuan, X.4    Isaacs, J.S.5    Bisht, K.S.6    Gius, D.7    Neckers, L.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.